Wird geladen...
MRD evaluation of AML in clinical practice: are we there yet?
MRD technologies increase our ability to measure response in acute myeloid leukemia (AML) beyond the limitations of morphology. When applied in clinical trials, molecular and immunophenotypic MRD assays have improved prognostic precision, providing a strong rationale for their use to guide treatment...
Gespeichert in:
| Veröffentlicht in: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society of Hematology
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6913462/ https://ncbi.nlm.nih.gov/pubmed/31808906 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019000060 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|